Thompson Siegel & Walmsley LLC Purchases 1,323,329 Shares of Clarivate Plc (NYSE:CLVT)

Thompson Siegel & Walmsley LLC increased its position in Clarivate Plc (NYSE:CLVTFree Report) by 14.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 10,498,588 shares of the company’s stock after buying an additional 1,323,329 shares during the period. Thompson Siegel & Walmsley LLC’s holdings in Clarivate were worth $53,333,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. KBC Group NV boosted its holdings in Clarivate by 33.2% in the 3rd quarter. KBC Group NV now owns 10,225 shares of the company’s stock worth $73,000 after buying an additional 2,549 shares during the period. Integrated Investment Consultants LLC boosted its holdings in Clarivate by 2.9% in the 3rd quarter. Integrated Investment Consultants LLC now owns 96,656 shares of the company’s stock worth $686,000 after buying an additional 2,696 shares during the period. OneDigital Investment Advisors LLC boosted its holdings in shares of Clarivate by 2.3% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 126,773 shares of the company’s stock valued at $900,000 after purchasing an additional 2,865 shares during the last quarter. Truist Financial Corp boosted its holdings in shares of Clarivate by 27.3% during the 4th quarter. Truist Financial Corp now owns 14,000 shares of the company’s stock valued at $71,000 after purchasing an additional 3,000 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in shares of Clarivate by 161.4% during the 4th quarter. GAMMA Investing LLC now owns 5,256 shares of the company’s stock valued at $27,000 after purchasing an additional 3,245 shares during the last quarter. Institutional investors own 85.72% of the company’s stock.

Clarivate Stock Down 1.1 %

CLVT opened at $4.03 on Thursday. The firm has a 50-day simple moving average of $4.91 and a two-hundred day simple moving average of $5.63. Clarivate Plc has a 52 week low of $3.96 and a 52 week high of $7.77. The company has a market capitalization of $2.78 billion, a PE ratio of -4.19 and a beta of 1.28. The company has a quick ratio of 0.88, a current ratio of 0.87 and a debt-to-equity ratio of 0.88.

Clarivate declared that its Board of Directors has approved a share buyback plan on Monday, December 16th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to buy up to 12.8% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

Separately, Royal Bank of Canada reissued a “sector perform” rating and set a $6.00 price objective on shares of Clarivate in a report on Thursday, February 20th.

Get Our Latest Research Report on CLVT

Clarivate Company Profile

(Free Report)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.

Featured Stories

Want to see what other hedge funds are holding CLVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clarivate Plc (NYSE:CLVTFree Report).

Institutional Ownership by Quarter for Clarivate (NYSE:CLVT)

Receive News & Ratings for Clarivate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarivate and related companies with MarketBeat.com's FREE daily email newsletter.